The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Roche
Randomized phase III trial of induction chemotherapy followed by chemoradiotherapy or chemotherapy alone for nonresectable locally advanced pancreatic cancer: First results of the CONKO-007 trial.
 
Rainer Fietkau
Honoraria - Abbvie; AstraZeneca; Merck Serono; Merck Serono; Merck Sharp & Dohme; MSD Oncology; Novocure; Sennewald GmbH
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; Merck Serono; MSD Oncology; Novocure
Speakers' Bureau - AstraZeneca; Merck Serono; MSD; Novocure; Sennewald GmbH
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Debios (Inst); Merck (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novocure (Inst); Siemens Healthineers (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Merck; Merck Serono; MSD Oncology; Novocure; Sennewald GmbH
 
Michael Ghadimi
No Relationships to Disclose
 
Robert Grützmann
No Relationships to Disclose
 
Uwe A Wittel
No Relationships to Disclose
 
Lutz Jacobasch
No Relationships to Disclose
 
Waldemar Uhl
No Relationships to Disclose
 
Roland S. Croner
Patents, Royalties, Other Intellectual Property - Siemens
(OPTIONAL) Uncompensated Relationships - Intuitive Surgical
 
Wolf Otto Bechstein
Honoraria - Astellas Pharma; Chiesi; Deutscher Ärzteverlag; GORE; Medupdate; Novartis; Sanofi; TERUMO
Consulting or Advisory Role - TERUMO
Travel, Accommodations, Expenses - Astellas Pharma; Chiesi; GORE; Medupdate; Novartis; Sanofi
 
Ulf Peter Neumann
Research Funding - Astellas Amgen BioPharama; Merck; Roche
Travel, Accommodations, Expenses - AstraZeneca Canada; Falk Foundation; Merck; Roche
 
Dirk Waldschmidt
No Relationships to Disclose
 
Stefan Hubert Boeck
Honoraria - MSD; SERVIER
 
Nicolas Moosmann
No Relationships to Disclose
 
Anke C. Reinacher-Schick
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; MCI Group; Merck Serono; MSD; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD; Pierre Fabre; Roche
Research Funding - AIO-Studien (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); BioNTech (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Ipsen (Inst); Lilly (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Roche
 
Henriette Golcher
No Relationships to Disclose
 
Werner Adler
No Relationships to Disclose
 
Sabine Semrau
Stock and Other Ownership Interests - Abbott (I); BioNTech; Crispr Therapeutics (I); Medtronic; Novartis; Siemens Healthineers; Stryker
Consulting or Advisory Role - PharmaMar
Speakers' Bureau - PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Annett Kallies
No Relationships to Disclose
 
Markus Hecht
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; MSD
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Sanofi (Inst)
 
Andrea Tannapfel
Honoraria - Amgen; Falk Foundation; Med.update; Merck; Pfizer
 
Helmut Oettle
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; SERVIER